From preclinical lots through routine bulk harvest testing of clinical and marketed batches, contamination testing helps ensure the safety of your biologic before it is released for use in animals and humans.

Charles River offers a portfolio of compendia assays for the detection of mycoplasma and bacterial contaminants and also in vivo, in vitro and biochemical viral detection assays. Our experts can design and develop the appropriate testing plan for your biologic, with a selection of available and customized assays that suit your specific needs.

You may also be interested in...

Cell Banking

Charles River is a partner you can trust to ensure the quality, consistency and integrity of your cell banks.

Lot Release

Charles River provides release testing services for bulk drug substances and clinical and marketed products and can act as a single provider for your global release testing.

Viral Clearance

Using a customized approach, we are able to provide technical advice and regulatory support to ensure that a successful and cost-effective viral clearance program is established executed.

Protein Characterization

We specialize in a broad range of analytical testing techniques to support characterization and development of both recombinant protein and peptide therapeutics.